Mutations in alpha-chain of C4BP that selectively affect its factor I cofactor function
Anna M Blom1, Bruno O Villoutreix, Björn Dahlbäck
1Lund University Department of Clinical Chemistry, University Hospital Malmö, The Wallenberg Laboratory, S-205 02 Malmö, Sweden and INSERM U428, Université Paris V, Paris 75006, France. Anna.Blom@klkemi.mas.lu.se
Insights
C4b-binding protein (C4BP) mutants selectively lost cofactor activity for C4b and C3b cleavage. Despite normal binding, these mutants failed to induce conformational changes necessary for protease function, highlighting specific structural requirements for complement regulation.
Area of Science:
- Immunology
- Biochemistry
- Molecular Biology
Background:
- C4b-binding protein (C4BP) is a key regulator of complement activation, inhibiting all pathways.
- C4BP functions as a cofactor for serine protease factor I (FI) in degrading complement factors C4b and C3b.
- C4BP structure involves alpha-chains (8 complement control protein domains) and a beta-chain (3 CCP domains).
Purpose of the Study:
- To investigate the role of specific mutations in C4BP's alpha-chain CCP3 domain on its cofactor activity.
- To determine if altered cofactor activity correlates with changes in C4b/C3b binding affinity or conformational changes.
Main Methods:
- Site-directed mutagenesis to create C4BP mutants (K126Q/K128Q and F144S/F149S) in the alpha-chain CCP3 domain.
- Surface plasmon resonance (SPR) to measure binding affinity of mutants to C4b/C3b.
- Assays to assess cofactor activity in C4b and C3b cleavage and inhibitory effects on C3-convertase.
Main Results:
- Two C4BP mutants (K126Q/K128Q and F144S/F149S) selectively lost cofactor activity for C4b and C3b cleavage.
- These mutants exhibited normal binding affinity for C4b/C3b and similar inhibitory effects on C3-convertase as wild-type C4BP.
- The data suggest that C4b and C3b do not undergo the same conformational changes upon binding to the mutants as with wild-type C4BP.
Conclusions:
- Specific residues within C4BP's alpha-chain CCP3 are critical for its cofactor function, independent of substrate binding affinity.
- The loss of cofactor activity in mutants is attributed to impaired conformational changes in C4b/C3b upon binding.
- These findings elucidate the mechanism of C4BP-mediated complement regulation and identify key structural determinants for cofactor activity.
Abstract:
C4b-binding protein (C4BP) inhibits all pathways of complement activation, acting as a cofactor to the serine protease factor I (FI) in the degradation of activated complement factors C4b and C3b. C4BP is a disulfide-linked polymer of seven alpha-chains and a unique beta-chain, the alpha- and beta-chains being composed of eight and three complement control protein (CCP) domains, respectively. In previous studies we have localized cofactor activity and binding of C4b to alpha-chain CCP1-3 of C4BP, whereas the binding of C3b required additionally CCP4. Likewise, introduced point mutations that decreased binding of C4b/C3b caused a decrease in cofactor activity. In the present study, we describe two mutants of C4BP, K126Q/K128Q and F144S/F149S, clustered on alpha-chain CCP3, which selectively lost their ability to act as cofactors in the cleavage of both C4b and C3b. Both mutants show the same binding affinity for C4b/C3b as measured by surface plasmon resonance and have the same inhibitory effect on formation and decay of the classical pathway C3-convertase as the wild type C4BP. It appears that C4b and C3b do not undergo the same conformational changes upon binding to the C4BP mutants as during the interaction with the wild type C4BP, which then results in the observed loss of the cofactor activity.
Related Concept Videos
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
Mutations
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Cofactors and Coenzymes
Cofactors can be metallic ions or organic molecules called coenzymes. These types of helper...
Cofactors and Coenzymes

